[YMAB] QoQ Quarter Result on 30-Sep-2021 [#Q3]

Stock
[YMAB] Y-mAbs Therapeutics, Inc.
Announcement Date
04-Nov-2021
Financial Year
2021
Quarter
30-Sep-2021 [#Q3]
Profit Trend
QoQ- -25.81%
YoY- 12.10%
Quarter Report
YMAB's Result
YMAB's Financial Summary
View:
Show?
Quarter Result
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Revenue 10,797 10,486 9,598 8,965 10,951 5,383 20,750 -35.38%
PBT -41,131 -28,068 -36,893 -28,858 -22,937 33,413 -19,933 62.29%
Tax 1,186 373 1,135 0 -216 338 2,086 -31.44%
NP -42,317 -28,441 -36,893 -28,858 -22,937 33,413 -19,933 65.40%
Tax Rate - - - - - -1.01% - -
Total Cost 53,114 38,927 46,491 37,823 33,888 -28,030 40,683 19.51%
Ratio Analysis
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
NP Margin -391.93 -271.23 -384.38 -321.90 -209.45 620.71 -96.06 155.99%
Per Share
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
EPS -0.97 -0.65 -0.85 -0.66 -0.53 0.80 -0.48 60.04%
EPS Diluted -0.97 -0.65 -0.85 -0.66 -0.53 0.75 -0.45 67.10%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.